RivoceranibVarious toxicities: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1859卷 / 1期

关键词：

D O I：

10.1007/s40278-021-97428-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：332 / 332

相关论文

共 50 条

[41] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1937 (1) : 72 - 72
[42] GemcitabineVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1754 (1) : 165 - 165
[43] ImmunosuppressantsVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1795 (1) : 151 - 151
[44] SecukinumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1715 (1) : 238 - 238
[45] AdalimumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1731 (1) : 13 - 13
[46] HydroxychloroquineVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1962 (1) : 211 - 211
[47] PropranololVarious toxicities: 4 case reports
Reactions Weekly, 2016, 1625 (1) : 172 - 172
[48] BevacizumabVarious toxicities: 4 case reports
Reactions Weekly, 2023, 1974 (1) : 79 - 79
[49] AntineoplasticsVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1752 (1) : 43 - 43
[50] TigecyclineVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1918 (1) : 459 - 459

← 1 2 3 4 5 →